There’s No Getting Around Mirum Pharmaceuticals Inc (NASDAQ: MIRM) Success

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.

Stocks Info

MIRM belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Mirum Pharmaceuticals Inc is $2.02B. A total of 0.31 million shares were traded on the day, compared to an average of 366.70K shares.

In the most recent transaction, Radovich Peter sold 1,998 shares of MIRM for 42.82 per share on Jan 07 ’25. After the transaction, the PRESIDENT AND COO now owns 27,015 company shares. In a previous transaction on Jan 07 ’25, Peetz Christopher sold 7,489 shares at 42.82 per share. MIRM shares that CHIEF EXECUTIVE OFFICER owns now total 119,359.

Among the insiders who sold shares, Howe Jolanda disposed of 750 shares on Jan 07 ’25 at a per-share price of $42.82. This resulted in the SVP, GLOBAL CONTROLLER holding 2,926 shares of MIRM after the transaction. In another insider transaction, Howe Jolanda sold 2,500 shares at $47.10 per share on Nov 14 ’24. Company shares held by the SVP, GLOBAL CONTROLLER now total 2,426.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, MIRM has a high of $48.89 and a low of $23.14.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. MIRM’s latest balance sheet shows that the firm has $156.54M in Cash & Short Term Investments as of fiscal 2021. There were $2.61M in debt and $42.60M in liabilities at the time. Its Book Value Per Share was $4.84, while its Total Shareholder’s Equity was $120.21M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MIRM is Buy with a score of 5.00.

Most Popular

Related Posts